By IDSE News Staff
National Institutes of Health–sponsored research in Malian adults found that all tested regimens of an experimental malaria vaccine provided durable protection from the malaria parasite (Lancet Infect Dis 2024 Aug 14. doi:10.1016/S1473-3099[24]00360-8).
The research was co-led by investigators from the NIH’s National Institute of Allergy and Infectious Diseases and the University of Sciences, Techniques and Technologies, in Bamako, Mali. The investigational vaccine
AUGUST 16, 2024